Targeting Stage 4 Cancer beyond ChemoOne tactic cancer cells and stage 4 cancers employ to develop and progress is byavoiding programmed cell death (apoptosis.) In a normal body, apoptosis is thenaturally-occurring process by which the body maintains healthy tissue function bydisposing of damaged cells. It is triggered by signals, including cell stress and DNAdamage.In many cancer patients, we see the process of apoptosis averted. This allows cancercells to continue to endure. In a healthy person, we may see apoptosis protect us frompotential cancer situations up to 10,000 times per day; so what we must ask ourselvesis “why then do Stage 4 Cancer patients divert this natural process?”Mutations Bring About Stubborn and Resistant Stage 4 CancersBoth internal and external cellular triggers can commence apoptosis. To catalyzeinternally, the process relies on protein p53. In the event of certain mutations to thisprotein’s gene, the protein can become inactive, thereby inhibiting internally-triggeredapoptosis functionality. This mutation is seen in up to 50 percent of all human cancers.By targeting this mutation, cancer treatments are enhanced significantly.Stage 4 Cancers May Dodge ChemotherapyIt is common knowledge that radiation’s and chemotherapy’s ability to damage cellDNA, indirectly promotes apoptosis. However, cancer takes advantage of a tricky
loophole to side-step what should be imminent trouble for its cells. As mutations toprotein p53 can shut down apoptosis from within the cell, in such circumstance, cancercells can escape the harm of conventional stage 4 treatments meant to wipe it out.Because Envita has seen this repeatedly over the last decade plus of working with themost difficult cancers, we have become proactive. Our protocols call for preventativetreatments designed to overcome p53 oncogene mutations through specializednutrition, and encouraging healthy apoptosis.Recognizing that nutritional, immunological, or impairments in toxin eliminationdeficiencies can create cancer-friendly environments is the first step. Taking actionagainst the causes of these environments is what sets Envita apart.Launching an Offensive on CancerBy simultaneously catalyzing apoptosis outside and within the cell, it is possible todestroy cancer cells that were previously deemed conventional treatment-resistant.Depending upon the stage and cancer type, Envita has a variety of treatments tosupport mitochondria dysfunction – coupled with nutrients employed to restore healthyfunctionality. These unique treatments are a part of why Envita has such and impressivetrack record against advanced and stage 4 cancers.Treatment Improved – Results AchievedEnvita’s Comprehensive Smart Oncology®(link to Envita cancer section) programintegrates successful oncology combinations with our aggressive natural therapies thataffect apoptosis in cancer cells by using tumor destruction methods that actually relysolely on p53. Visit our PPMR process( link to Envita home or ppmr) or contact usspeak to one of our patient-care educators so that we can put an immediate plan inplace for you.